ID   MTMR2_HUMAN             Reviewed;         643 AA.
AC   Q13614; A6NN98; Q9UPS9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 4.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Myotubularin-related protein 2;
DE   AltName: Full=Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;
DE            EC=3.1.3.95 {ECO:0000269|PubMed:12668758};
DE   AltName: Full=Phosphatidylinositol-3-phosphate phosphatase;
DE            EC=3.1.3.64 {ECO:0000269|PubMed:11733541, ECO:0000269|PubMed:12668758};
GN   Name=MTMR2; Synonyms=KIAA1073;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT THR-3.
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT THR-3.
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 384-643 (ISOFORM 1).
RX   PubMed=9736772; DOI=10.1093/hmg/7.11.1703;
RA   Laporte J., Blondeau F., Buj-Bello A., Tentler D., Kretz C., Dahl N.,
RA   Mandel J.-L.;
RT   "Characterization of the myotubularin dual specificity phosphatase
RT   gene family from yeast to human.";
RL   Hum. Mol. Genet. 7:1703-1712(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 384-514 (ISOFORM 1).
RX   PubMed=8640223; DOI=10.1038/ng0696-175;
RA   Laporte J., Hu L.-J., Kretz C., Mandel J.-L., Kioschis P., Coy J.,
RA   Klauck S.M., Poutska A., Dahl N.;
RT   "A gene mutated in X-linked myotubular myopathy defines a new putative
RT   tyrosine phosphatase family conserved in yeast.";
RL   Nat. Genet. 13:175-182(1996).
RN   [8]
RP   INVOLVEMENT IN CMT4B1.
RX   PubMed=10802647; DOI=10.1038/75542;
RA   Bolino A., Muglia M., Conforti F.L., LeGuern E., Salih M.A.M.,
RA   Georgiou D.-M., Christodoulou K., Hausmanowa-Petrusewicz I.,
RA   Mandich P., Schenone A., Gambardella A., Bono F., Quattrone A.,
RA   Devoto M., Monaco A.P.;
RT   "Charcot-Marie-Tooth type 4B is caused by mutations in the gene
RT   encoding myotubularin-related protein-2.";
RL   Nat. Genet. 25:17-19(2000).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11733541; DOI=10.1074/jbc.M111087200;
RA   Kim S.A., Taylor G.S., Torgersen K.M., Dixon J.E.;
RT   "Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated
RT   in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.";
RL   J. Biol. Chem. 277:4526-4531(2002).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, IDENTIFICATION BY
RP   MASS SPECTROMETRY, SUBUNIT, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   LEU-607, AND INTERACTION WITH SBF1.
RX   PubMed=12668758; DOI=10.1073/pnas.0431052100;
RA   Kim S.-A., Vacratsis P.O., Firestein R., Cleary M.L., Dixon J.E.;
RT   "Regulation of myotubularin-related (MTMR)2 phosphatidylinositol
RT   phosphatase by MTMR5, a catalytically inactive phosphatase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4492-4497(2003).
RN   [11]
RP   INTERACTION WITH SBF2, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=15998640; DOI=10.1074/jbc.M505159200;
RA   Robinson F.L., Dixon J.E.;
RT   "The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a
RT   membrane-associated pseudophosphatase also mutated in type 4B Charcot-
RT   Marie-Tooth disease.";
RL   J. Biol. Chem. 280:31699-31707(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-58.
RX   PubMed=21372139; DOI=10.1074/jbc.M110.209122;
RA   Franklin N.E., Taylor G.S., Vacratsis P.O.;
RT   "Endosomal targeting of the phosphoinositide 3-phosphatase MTMR2 is
RT   regulated by an N-terminal phosphorylation site.";
RL   J. Biol. Chem. 286:15841-15853(2011).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF MUTANT SER-417 IN COMPLEX
RP   WITH PHOSPHOINOSITIDE, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   MUTAGENESIS OF CYS-417; ASP-419 AND ASP-422.
RX   PubMed=14690594; DOI=10.1016/S1097-2765(03)00486-6;
RA   Begley M.J., Taylor G.S., Kim S.-A., Veine D.M., Dixon J.E.,
RA   Stuckey J.A.;
RT   "Crystal structure of a phosphoinositide phosphatase, MTMR2: insights
RT   into myotubular myopathy and Charcot-Marie-Tooth syndrome.";
RL   Mol. Cell 12:1391-1402(2003).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 71-586 OF MUTANT SER-417 IN
RP   COMPLEX WITH PHOSPHOINOSITIDES, COILED-COIL DOMAIN, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND MUTAGENESIS OF CYS-417.
RX   PubMed=16410353; DOI=10.1073/pnas.0510006103;
RA   Begley M.J., Taylor G.S., Brock M.A., Ghosh P., Woods V.L.,
RA   Dixon J.E.;
RT   "Molecular basis for substrate recognition by MTMR2, a myotubularin
RT   family phosphoinositide phosphatase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:927-932(2006).
RN   [19]
RP   VARIANT CMT4B1 TRP-283.
RX   PubMed=12398840; DOI=10.1016/S0960-8966(02)00046-9;
RA   Nelis E., Erdem S., Tan E., Loefgren A., Ceuterick C., De Jonghe P.,
RA   Van Broeckhoven C., Timmerman V., Topaloglu H.;
RT   "A novel homozygous missense mutation in the myotubularin-related
RT   protein 2 gene associated with recessive Charcot-Marie-Tooth disease
RT   with irregularly folded myelin sheaths.";
RL   Neuromuscul. Disord. 12:869-873(2002).
CC   -!- FUNCTION: Phosphatase that acts on lipids with a phosphoinositol
CC       headgroup. Has phosphatase activity towards phosphatidylinositol
CC       3-phosphate and phosphatidylinositol 3,5-bisphosphate.
CC       {ECO:0000269|PubMed:11733541, ECO:0000269|PubMed:12668758,
CC       ECO:0000269|PubMed:21372139}.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 3-phosphate +
CC       H(2)O = 1-phosphatidyl-1D-myo-inositol + phosphate.
CC       {ECO:0000269|PubMed:11733541, ECO:0000269|PubMed:12668758}.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 3,5-
CC       bisphosphate + H(2)O = 1-phosphatidyl-1D-myo-inositol 5-phosphate
CC       + phosphate. {ECO:0000269|PubMed:12668758}.
CC   -!- ENZYME REGULATION: Interaction with SBF1 increases phosphatase
CC       activity. {ECO:0000269|PubMed:12668758}.
CC   -!- SUBUNIT: Homooligomer and heterooligomer. Interacts with SBF1 and
CC       SBF2. {ECO:0000269|PubMed:12668758, ECO:0000269|PubMed:14690594,
CC       ECO:0000269|PubMed:15998640, ECO:0000269|PubMed:16410353}.
CC   -!- INTERACTION:
CC       P07196:NEFL; NbExp=2; IntAct=EBI-475631, EBI-475646;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11733541,
CC       ECO:0000269|PubMed:12668758}. Early endosome membrane
CC       {ECO:0000269|PubMed:21372139}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:21372139}. Note=Partly associated with
CC       membranes. {ECO:0000269|PubMed:12668758,
CC       ECO:0000269|PubMed:21372139, ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13614-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13614-2; Sequence=VSP_044933;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The coiled-coil domain mediates interaction with SBF2.
CC   -!- PTM: Phosphorylation at Ser-58 decreases MTMR2 localization to
CC       endocytic vesicular structures. {ECO:0000269|PubMed:21372139}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 4B1 (CMT4B1) [MIM:601382]: A
CC       recessive demyelinating form of Charcot-Marie-Tooth disease, a
CC       disorder of the peripheral nervous system, characterized by
CC       progressive weakness and atrophy, initially of the peroneal
CC       muscles and later of the distal muscles of the arms. Charcot-
CC       Marie-Tooth disease is classified in two main groups on the basis
CC       of electrophysiologic properties and histopathology: primary
CC       peripheral demyelinating neuropathies (designated CMT1 when they
CC       are dominantly inherited) and primary peripheral axonal
CC       neuropathies (CMT2). Demyelinating neuropathies are characterized
CC       by severely reduced nerve conduction velocities (less than 38
CC       m/sec), segmental demyelination and remyelination with onion bulb
CC       formations on nerve biopsy, slowly progressive distal muscle
CC       atrophy and weakness, absent deep tendon reflexes, and hollow
CC       feet. By convention autosomal recessive forms of demyelinating
CC       Charcot-Marie-Tooth disease are designated CMT4.
CC       {ECO:0000269|PubMed:10802647, ECO:0000269|PubMed:12398840}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class myotubularin subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA83025.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Inherited peripheral neuropathies mutation db;
CC       URL="http://www.molgen.ua.ac.be/CMTMutations/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028996; BAA83025.2; ALT_INIT; mRNA.
DR   EMBL; AK302940; BAG64098.1; -; mRNA.
DR   EMBL; AP000870; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001877; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW66971.1; -; Genomic_DNA.
DR   EMBL; BC052990; AAH52990.1; -; mRNA.
DR   EMBL; U58033; AAC79118.1; -; mRNA.
DR   CCDS; CCDS8305.1; -. [Q13614-1]
DR   CCDS; CCDS8306.1; -. [Q13614-2]
DR   PIR; T09497; T09497.
DR   RefSeq; NP_001230500.1; NM_001243571.1. [Q13614-2]
DR   RefSeq; NP_057240.3; NM_016156.5. [Q13614-1]
DR   RefSeq; NP_958435.1; NM_201278.2. [Q13614-2]
DR   RefSeq; NP_958438.1; NM_201281.2. [Q13614-2]
DR   RefSeq; XP_005274431.1; XM_005274374.2. [Q13614-2]
DR   RefSeq; XP_005274432.1; XM_005274375.2. [Q13614-2]
DR   RefSeq; XP_006718997.1; XM_006718934.2. [Q13614-2]
DR   RefSeq; XP_006718998.1; XM_006718935.2. [Q13614-2]
DR   RefSeq; XP_006718999.1; XM_006718936.3. [Q13614-2]
DR   RefSeq; XP_016874006.1; XM_017018517.1. [Q13614-2]
DR   RefSeq; XP_016874007.1; XM_017018518.1. [Q13614-2]
DR   UniGene; Hs.181326; -.
DR   PDB; 1LW3; X-ray; 2.30 A; A=1-643.
DR   PDB; 1M7R; X-ray; 2.60 A; A/B=1-643.
DR   PDB; 1ZSQ; X-ray; 1.82 A; A=73-586.
DR   PDB; 1ZVR; X-ray; 1.98 A; A=73-586.
DR   PDBsum; 1LW3; -.
DR   PDBsum; 1M7R; -.
DR   PDBsum; 1ZSQ; -.
DR   PDBsum; 1ZVR; -.
DR   ProteinModelPortal; Q13614; -.
DR   SMR; Q13614; -.
DR   BioGrid; 114415; 14.
DR   IntAct; Q13614; 5.
DR   MINT; MINT-6774021; -.
DR   STRING; 9606.ENSP00000345752; -.
DR   SwissLipids; SLP:000001135; -.
DR   DEPOD; Q13614; -.
DR   iPTMnet; Q13614; -.
DR   PhosphoSitePlus; Q13614; -.
DR   SwissPalm; Q13614; -.
DR   BioMuta; MTMR2; -.
DR   DMDM; 212276520; -.
DR   EPD; Q13614; -.
DR   MaxQB; Q13614; -.
DR   PaxDb; Q13614; -.
DR   PeptideAtlas; Q13614; -.
DR   PRIDE; Q13614; -.
DR   Ensembl; ENST00000346299; ENSP00000345752; ENSG00000087053. [Q13614-1]
DR   Ensembl; ENST00000352297; ENSP00000343737; ENSG00000087053. [Q13614-2]
DR   Ensembl; ENST00000393223; ENSP00000376915; ENSG00000087053. [Q13614-2]
DR   Ensembl; ENST00000409459; ENSP00000386882; ENSG00000087053. [Q13614-2]
DR   GeneID; 8898; -.
DR   KEGG; hsa:8898; -.
DR   UCSC; uc001pft.4; human. [Q13614-1]
DR   CTD; 8898; -.
DR   DisGeNET; 8898; -.
DR   GeneCards; MTMR2; -.
DR   GeneReviews; MTMR2; -.
DR   HGNC; HGNC:7450; MTMR2.
DR   HPA; HPA049831; -.
DR   MalaCards; MTMR2; -.
DR   MIM; 601382; phenotype.
DR   MIM; 603557; gene.
DR   neXtProt; NX_Q13614; -.
DR   OpenTargets; ENSG00000087053; -.
DR   Orphanet; 99955; Charcot-Marie-Tooth disease type 4B1.
DR   PharmGKB; PA31253; -.
DR   eggNOG; KOG1089; Eukaryota.
DR   eggNOG; ENOG410XPTU; LUCA.
DR   GeneTree; ENSGT00760000118832; -.
DR   HOGENOM; HOG000210598; -.
DR   HOVERGEN; HBG000220; -.
DR   InParanoid; Q13614; -.
DR   KO; K18081; -.
DR   OMA; NDMWRAT; -.
DR   OrthoDB; EOG091G04DS; -.
DR   PhylomeDB; Q13614; -.
DR   TreeFam; TF315197; -.
DR   BRENDA; 3.1.3.64; 2681.
DR   BRENDA; 3.1.3.95; 2681.
DR   Reactome; R-HSA-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-HSA-1660517; Synthesis of PIPs at the late endosome membrane.
DR   ChiTaRS; MTMR2; human.
DR   EvolutionaryTrace; Q13614; -.
DR   GeneWiki; MTMR2; -.
DR   GenomeRNAi; 8898; -.
DR   PRO; PR:Q13614; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000087053; -.
DR   CleanEx; HS_MTMR2; -.
DR   ExpressionAtlas; Q13614; baseline and differential.
DR   Genevisible; Q13614; HS.
DR   GO; GO:0030424; C:axon; ISS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:BHF-UCL.
DR   GO; GO:0043197; C:dendritic spine; ISS:BHF-UCL.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; ISS:BHF-UCL.
DR   GO; GO:0097060; C:synaptic membrane; ISS:BHF-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:BHF-UCL.
DR   GO; GO:0005774; C:vacuolar membrane; IEA:Ensembl.
DR   GO; GO:0052629; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0097062; P:dendritic spine maintenance; ISS:BHF-UCL.
DR   GO; GO:0046855; P:inositol phosphate dephosphorylation; IEA:Ensembl.
DR   GO; GO:0032288; P:myelin assembly; IEA:Ensembl.
DR   GO; GO:0045806; P:negative regulation of endocytosis; ISS:BHF-UCL.
DR   GO; GO:0090394; P:negative regulation of excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:0031642; P:negative regulation of myelination; IEA:Ensembl.
DR   GO; GO:2000645; P:negative regulation of receptor catabolic process; ISS:BHF-UCL.
DR   GO; GO:0002091; P:negative regulation of receptor internalization; ISS:BHF-UCL.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:UniProtKB.
DR   GO; GO:2000643; P:positive regulation of early endosome to late endosome transport; ISS:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; NAS:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IEA:Ensembl.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR004182; GRAM.
DR   InterPro; IPR010569; Myotubularin-like_Pase_dom.
DR   InterPro; IPR030564; Myotubularin_fam.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   PANTHER; PTHR10807; PTHR10807; 1.
DR   Pfam; PF02893; GRAM; 1.
DR   Pfam; PF06602; Myotub-related; 1.
DR   SMART; SM00568; GRAM; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS51339; PPASE_MYOTUBULARIN; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Charcot-Marie-Tooth disease;
KW   Coiled coil; Complete proteome; Cytoplasm; Disease mutation; Endosome;
KW   Hydrolase; Lipid metabolism; Membrane; Neurodegeneration; Neuropathy;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    643       Myotubularin-related protein 2.
FT                                /FTId=PRO_0000094934.
FT   DOMAIN       68    139       GRAM.
FT   DOMAIN      205    580       Myotubularin phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00669}.
FT   REGION      330    333       Substrate binding.
FT                                {ECO:0000269|PubMed:14690594}.
FT   REGION      355    356       Substrate binding.
FT                                {ECO:0000269|PubMed:14690594}.
FT   REGION      417    423       Substrate binding.
FT                                {ECO:0000269|PubMed:14690594}.
FT   COILED      593    627       {ECO:0000269|PubMed:16410353}.
FT   COMPBIAS      4     53       Ser-rich.
FT   ACT_SITE    417    417       Phosphocysteine intermediate.
FT   BINDING     463    463       Substrate.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z2D1}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z2D1}.
FT   MOD_RES      58     58       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:21372139}.
FT   VAR_SEQ       1     72       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044933.
FT   VARIANT       3      3       K -> T (in dbSNP:rs3824874).
FT                                {ECO:0000269|PubMed:10470851,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_047255.
FT   VARIANT     283    283       R -> W (in CMT4B1).
FT                                {ECO:0000269|PubMed:12398840}.
FT                                /FTId=VAR_047947.
FT   VARIANT     545    545       N -> S (in dbSNP:rs558018).
FT                                /FTId=VAR_047256.
FT   MUTAGEN     417    417       C->S: Loss of activity.
FT                                {ECO:0000269|PubMed:14690594,
FT                                ECO:0000269|PubMed:16410353}.
FT   MUTAGEN     419    419       D->A: No effect.
FT                                {ECO:0000269|PubMed:14690594}.
FT   MUTAGEN     422    422       D->A: Loss of activity.
FT                                {ECO:0000269|PubMed:14690594}.
FT   MUTAGEN     607    607       L->Y: Reduces homodimerization and
FT                                interaction with SBF1.
FT                                {ECO:0000269|PubMed:12668758}.
FT   STRAND       84     95       {ECO:0000244|PDB:1ZSQ}.
FT   TURN         96     98       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND       99    121       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      123    128       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       129    131       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      132    138       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      145    147       {ECO:0000244|PDB:1ZVR}.
FT   STRAND      149    155       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        156    158       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      159    164       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       167    169       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       172    182       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        185    189       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       193    195       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       205    207       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       211    217       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      223    228       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        230    233       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      234    236       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      242    247       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       252    261       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       263    265       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      269    273       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        275    277       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      280    284       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        290    293       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       297    309       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      310    312       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      314    320       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       324    333       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        340    342       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      346    350       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       356    370       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       376    378       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       379    386       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       388    407       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      413    416       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      418    422       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       423    435       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       437    440       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       442    452       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        453    457       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       460    464       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        465    467       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       479    493       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        495    497       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       502    514       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      516    518       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      522    524       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       525    530       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       533    536       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       540    545       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       548    551       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        554    557       {ECO:0000244|PDB:1ZSQ}.
FT   STRAND      560    562       {ECO:0000244|PDB:1ZSQ}.
FT   TURN        570    572       {ECO:0000244|PDB:1ZSQ}.
FT   HELIX       577    580       {ECO:0000244|PDB:1ZSQ}.
SQ   SEQUENCE   643 AA;  73381 MW;  10FD6508D0CDA719 CRC64;
     MEKSSSCESL GSQPAAARPP SVDSLSSAST SHSENSVHTK SASVVSSDSI STSADNFSPD
     LRVLRESNKL AEMEEPPLLP GENIKDMAKD VTYICPFTGA VRGTLTVTNY RLYFKSMERD
     PPFVLDASLG VINRVEKIGG ASSRGENSYG LETVCKDIRN LRFAHKPEGR TRRSIFENLM
     KYAFPVSNNL PLFAFEYKEV FPENGWKLYD PLLEYRRQGI PNESWRITKI NERYELCDTY
     PALLVVPANI PDEELKRVAS FRSRGRIPVL SWIHPESQAT ITRCSQPMVG VSGKRSKEDE
     KYLQAIMDSN AQSHKIFIFD ARPSVNAVAN KAKGGGYESE DAYQNAELVF LDIHNIHVMR
     ESLRKLKEIV YPNIEETHWL SNLESTHWLE HIKLILAGAL RIADKVESGK TSVVVHCSDG
     WDRTAQLTSL AMLMLDGYYR TIRGFEVLVE KEWLSFGHRF QLRVGHGDKN HADADRSPVF
     LQFIDCVWQM TRQFPTAFEF NEYFLITILD HLYSCLFGTF LCNSEQQRGK ENLPKRTVSL
     WSYINSQLED FTNPLYGSYS NHVLYPVASM RHLELWVGYY IRWNPRMKPQ EPIHNRYKEL
     LAKRAELQKK VEELQREISN RSTSSSERAS SPAQCVTPVQ TVV
//
